---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-001879"
form_type: "8-K"
ticker: "ACH"
cik: "0000075252"
company_name: "ACCENDRA HEALTH INC/VA/"
filed_at: "2025-02-28T23:59:59+00:00"
generated_at: "2026-05-26T00:41:23.383156+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Owens & Minor reports Q4 GAAP net loss $296M, adjusted EPS $0.55; exploring sale of P&HS segment

## Summary
- Q4 GAAP net loss $296M ($3.84 loss per share); adjusted net income $43M ($0.55 EPS).
- Total revenue $2,696M in Q4, $10,701M for FY2024; adjusted EBITDA $138M Q4, $523M FY.
- Company actively engaging in discussions for potential sale of Products & Healthcare Services segment.
- Board authorized share repurchase program up to $100 million; also reduced debt $244M in 2024.
- 2025 guidance midpoint expects double-digit adjusted EBITDA and adjusted EPS growth, improving cash flow.

## SEC filing metadata
- accession: 0001558370-25-001879
- form_type: 8-K
- ticker: ACH
- cik: 0000075252
- company_name: ACCENDRA HEALTH INC/VA/
- filed_at: 2025-02-28T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/75252/000155837025001879/0001558370-25-001879-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/75252/000155837025001879/omi-20250228x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-001879
- JSON: https://secwatch.observer/filing/0001558370-25-001879.json
- Plain text: https://secwatch.observer/filing/0001558370-25-001879.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.